English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Select site language

Docetaxel Teva (docetaxel) – Conditions or restrictions regarding supply and use - L01CD02

Updated on site: 06-Oct-2017

Medication nameDocetaxel Teva
ATC CodeL01CD02
Substancedocetaxel
ManufacturerTeva B.V.  

A.MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturer(s) responsible for batch release

Pharmachemie BV.

Swensweg 5, Postbus 552, 2003 RN Haarlem

The Netherlands

TEVA Pharmaceutical Works Private Limited Company

H-2100 Gödöllő, Táncsics Mihály út 82

Hungary

The printed package leaflet of the medicinal product must state the name and address of the manufacturer responsible for the release of the concerned batch.

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).

C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION

Periodic Safety Update Reports

The marketing authorisation holder shall submit periodic safety update reports for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European Medicines web-portal.

D. CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT

Risk Management Plan (MRP)

Not applicable.

Obligation to conduct post-authorisation measures

Not applicable

Comments

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Help
  • Get it on Google Play
  • About
  • Info on site by:

  • Presented by RXed.eu

  • 27558

    prescription drugs listed